Skip to main content
Premium Trial:

Request an Annual Quote

Cota Raises $40M in Series C Round

NEW YORK (GenomeWeb) – Healthcare data analytics company Cota announced today that it has closed a $40 million Series C round of financing.

The round was led by Iqvia with participation from EW Healthcare Partners and Memorial Sloan Kettering Cancer Center, as well as existing investors Boston Millennia Partners, Horizon Blue Cross Blue Shield of New Jersey, Hackensack Meridian Health, and Atoc Holdings. In connection with the transaction, Iqvia has received a seat on Cota's board.

The company said it would use the funding to advance its Cota Nodal Address classification system — which creates patient cohorts by categorizing patient-specific medical histories, information on their diseases, and planned therapies — and to scale up its other real-world evidence and analytics platforms geared toward healthcare providers, payors, and life science companies.

Earlier this year, Cota was selected to help develop precision medicine and research programs at the Miami Cancer Institute. And in late 2017, the firm partnered with Memorial Sloan Kettering Cancer Center to build clinical and genomic data sets for personalized medicine. In 2016, Cota began collaborating with Guardant Health to study barriers to genomic profiling in lung cancer patients.

The Scan

Vaccine Update Recommended

A US Food and Drug Administration panel recommends booster vaccines be updated to target Omicron, CNBC reports.

US to Make More Vaccines for Monkeypox Available

The US is to make nearly 300,000 vaccine doses available in the coming weeks to stem the spread of human monkeypox virus, according to NPR.

Sentence Appealed

The Associated Press reports that Swedish prosecutors are appealing the sentence given to a surgeon once lauded for transplanting synthetic tracheas but then convicted of causing bodily harm.

Genome Biology Papers on COVID-19 Effector Genes, Virtual ChIP-seq, scDART

In Genome Biology this week: proposed COVID-19 effector genes, method to predict transcription factor binding patterns, and more.